Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial
Crossref DOI link: https://doi.org/10.1186/s12890-017-0462-y
Published Online: 2017-09-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Behr, Jürgen
Neuser, Petra
Prasse, Antje
Kreuter, Michael
Rabe, Klaus
Schade-Brittinger, Carmen
Wagner, Jasmin
Günther, Andreas
Funding for this research was provided by:
German Center for Lung Research
F. Hoffmann-La Roche
